Matches in Wikidata for { <http://www.wikidata.org/entity/Q91318958> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q91318958 description "article scientifique publié en 2019" @default.
- Q91318958 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91318958 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91318958 description "scientific article published on 01 October 2019" @default.
- Q91318958 description "wetenschappelijk artikel" @default.
- Q91318958 description "наукова стаття, опублікована 1 жовтня 2019" @default.
- Q91318958 name "The efficacy of glycemic control with continuous glucose monitoring on atheroma progression: rationale and design of the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Melli" @default.
- Q91318958 name "The efficacy of glycemic control with continuous glucose monitoring on atheroma progression: rationale and design of the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Melli" @default.
- Q91318958 type Item @default.
- Q91318958 label "The efficacy of glycemic control with continuous glucose monitoring on atheroma progression: rationale and design of the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Melli" @default.
- Q91318958 label "The efficacy of glycemic control with continuous glucose monitoring on atheroma progression: rationale and design of the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Melli" @default.
- Q91318958 prefLabel "The efficacy of glycemic control with continuous glucose monitoring on atheroma progression: rationale and design of the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Melli" @default.
- Q91318958 prefLabel "The efficacy of glycemic control with continuous glucose monitoring on atheroma progression: rationale and design of the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Melli" @default.
- Q91318958 P1433 Q91318958-4A292B68-3427-4AF9-BC74-AAE1821EA256 @default.
- Q91318958 P1476 Q91318958-B09E18B2-BC47-4F1E-B0C7-CC45DB621D82 @default.
- Q91318958 P2093 Q91318958-007DD2D1-0137-4A19-8FDB-1AB51D0F0BD2 @default.
- Q91318958 P2093 Q91318958-090451F9-23F5-4366-9E3B-B10D71F4B6A2 @default.
- Q91318958 P2093 Q91318958-35484645-C371-4AF6-ADC1-9B27A9A8FD22 @default.
- Q91318958 P2093 Q91318958-788C87DC-5024-4C23-9B51-C895AA00B9C5 @default.
- Q91318958 P2093 Q91318958-7A90AD8B-F6DF-43E4-85A2-201ACDA74EF7 @default.
- Q91318958 P2093 Q91318958-92818627-0CC2-4AF3-9115-1EB1687F4571 @default.
- Q91318958 P2093 Q91318958-9887B3DC-8B26-45B9-AB62-A8D3A81BDE1D @default.
- Q91318958 P2093 Q91318958-98F893A2-E7E4-4658-BC94-5E81CAB80B70 @default.
- Q91318958 P2093 Q91318958-9EDEA4A9-EE27-4444-B3EF-082CC14C131D @default.
- Q91318958 P2093 Q91318958-A0A450BE-3FFC-4311-8AAB-A098F1EA2E72 @default.
- Q91318958 P2093 Q91318958-A7AB64EA-60A9-4EAB-8B41-3AFAA5BCDF93 @default.
- Q91318958 P2093 Q91318958-C6B5E026-938F-42E8-9E41-2288733AF9D2 @default.
- Q91318958 P2093 Q91318958-CA1D8EA6-B963-4091-AD3B-546CDD514F38 @default.
- Q91318958 P2093 Q91318958-CE32D8F9-92FD-476F-8FA6-0384E2C55827 @default.
- Q91318958 P2093 Q91318958-D6AB0C8E-B7AA-4DEA-B6F3-80D84B8D4C50 @default.
- Q91318958 P2093 Q91318958-F21E5D17-1844-4548-9986-4A85FBAC273C @default.
- Q91318958 P2093 Q91318958-FBAB7408-0013-43B7-B41E-F58B9A50BCAD @default.
- Q91318958 P304 Q91318958-2850E1DB-9ED7-4EB8-8B3A-1CD5904B7E73 @default.
- Q91318958 P31 Q91318958-FC2DA861-F5DD-475D-8698-97AE4FBAD836 @default.
- Q91318958 P356 Q91318958-5CF6BD11-BC88-4CF5-8AE1-07C2A97B8ED7 @default.
- Q91318958 P433 Q91318958-5980E461-31B5-4B08-83E0-8E343A33F3A3 @default.
- Q91318958 P478 Q91318958-0DFE5CB0-3665-42F9-8EC0-BD83AC8BC367 @default.
- Q91318958 P577 Q91318958-53291934-8369-4108-8031-528CE7EBF7EF @default.
- Q91318958 P698 Q91318958-90526797-7803-41B4-AEB6-D230435B267C @default.
- Q91318958 P921 Q91318958-EC660CAB-B2F8-4045-8D3D-B02B2118703A @default.
- Q91318958 P921 Q91318958-F57A28DC-830A-4968-B1F7-72C162B94E12 @default.
- Q91318958 P932 Q91318958-B652DCBD-FB76-4A63-8C71-822732B42768 @default.
- Q91318958 P356 CDT.2019.09.02 @default.
- Q91318958 P698 31737515 @default.
- Q91318958 P1433 Q26842243 @default.
- Q91318958 P1476 "The efficacy of glycemic control with continuous glucose monitoring on atheroma progression: rationale and design of the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Mellitus (OPTIMAL)" @default.
- Q91318958 P2093 "Cheol Son" @default.
- Q91318958 P2093 "Hisashi Makino" @default.
- Q91318958 P2093 "Kiminori Hosoda" @default.
- Q91318958 P2093 "Kunihiro Nishimura" @default.
- Q91318958 P2093 "Kyoko Honda-Kohmo" @default.
- Q91318958 P2093 "Masaki Matsubara" @default.
- Q91318958 P2093 "Michio Noguchi" @default.
- Q91318958 P2093 "Miki Matsuo" @default.
- Q91318958 P2093 "Ryo Koezuka" @default.
- Q91318958 P2093 "Satoshi Yasuda" @default.
- Q91318958 P2093 "Tamiko Tamanaha" @default.
- Q91318958 P2093 "Teruo Noguchi" @default.
- Q91318958 P2093 "Tsutomu Tomita" @default.
- Q91318958 P2093 "Yasuhide Asaumi" @default.
- Q91318958 P2093 "Yoko Ohata" @default.
- Q91318958 P2093 "Yoshihiro Miyamoto" @default.
- Q91318958 P2093 "Yu Kataoka" @default.
- Q91318958 P304 "431-438" @default.
- Q91318958 P31 Q13442814 @default.
- Q91318958 P356 "10.21037/CDT.2019.09.02" @default.
- Q91318958 P433 "5" @default.
- Q91318958 P478 "9" @default.
- Q91318958 P577 "2019-10-01T00:00:00Z" @default.
- Q91318958 P698 "31737515" @default.
- Q91318958 P921 Q3025883 @default.
- Q91318958 P921 Q95987978 @default.
- Q91318958 P932 "6837914" @default.